Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility

This publication has 5 references indexed in Scilit:

• Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia
  The Lancet, 2002
• Deferiprone versus Deferoxamine in Patients with Thalassemia Major: A Randomized Clinical Trial
  Blood Cells, Molecules, and Diseases, 2002
• Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)
  Transfusion Science, 2000
• DESFERRIOXAMINE TO IMPROVE CARDIAC FUNCTION IN IRON-OVERLOADED PATIENTS WITH THALASSAEMIA MAJOR
  The Lancet, 1984
• Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded Subjects
  British Journal of Haematology, 1979